The mission of the Wisconsin Alzheimer's Disease Research Center (ADRC) Data Management and Biostatistics Core (Core C) is to promote excellence by providing outstanding data management, biomedical computing, and biostatistical support to Wisconsin ADRC investigators and affiliates. To accomplish this objective, Core C has the following specific aims:
Specific Aim 1 : To provide and maintain quality protocol and data management for projects affiliated with the Wisconsin ADRC;
Specific Aim 2 : To provide a biomedical computing infrastructure and services for projects affiliated with the Wisconsin ADRC;
Specific Aim 3 : To provide comprehensive statistical support (including study design, implementation, data analysis, and methodology development) to all projects associated with the Wisconsin ADRC;
Specific Aim 4 : To work with the NACC to create a smooth and efficient exchange of data and to collaborate with other ADRCs, ADCCs, and AD researchers;
Specific Aim 5 : To interface effectively with each of the other Wisconsin ADRC Cores to provide comprehensive, high-quality support to achieve the overall mission of the ADRC. The proposed specific aims will utilize and solidify existing resources to ensure an effective ADRC that will support cutting-edge clinical, basic, and translational research on a cohort at risk for AD (i.e., WRAP), as well as those with MCI, AD and related neurodegenerative disorders. These resources include extensive existing collaborations, financial commitments, data sources and acknowledged excellence in data management, an existing state-wide network, advanced informatics capabilities, and acknowledged expertise in biostatistics and informatics

Public Health Relevance

The Data Management and Biostatistics Core will provide critical support for the Wisconsin ADRC to accomplish its objectives targeting one of the most common and devastating neurodegenerative illnesses known to afflict humans. Given the projected exponential increase in the number of Americans likely to be affected by AD, it is pivotal that novel treatment and prevention strategies be identified. The Wisconsin ADRC will help accomplish this national priority.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Wisconsin Madison
United States
Zip Code
Brenowitz, Willa D; Keene, C Dirk; Hawes, Stephen E et al. (2017) Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples. Neurobiol Aging 53:83-92
Law, Lena L; Schultz, Stephanie A; Boots, Elizabeth A et al. (2017) Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease. J Alzheimers Dis 56:351-359
Moga, Daniela C; Abner, Erin L; Wu, Qishan et al. (2017) Bladder antimuscarinics and cognitive decline in elderly patients. Alzheimers Dement (N Y) 3:139-148
Katsumata, Yuriko; Nelson, Peter T; Ellingson, Sally R et al. (2017) Gene-based association study of genes linked to hippocampal sclerosis of aging neuropathology: GRN, TMEM106B, ABCC9, and KCNMB2. Neurobiol Aging 53:193.e17-193.e25
Dempsey, Robert J; Jackson, Daren C; Wilbrand, Stephanie M et al. (2017) The Preservation of Cognition 1 Yr After Carotid Endarterectomy in Patients With Prior Cognitive Decline. Neurosurgery :
Hullinger, Rikki; Puglielli, Luigi (2017) Molecular and cellular aspects of age-related cognitive decline and Alzheimer's disease. Behav Brain Res 322:191-205
Houlahan, Beth; Carlson, Elizabeth; Kind, Amy et al. (2017) Initiation of a Transitions Program: ""Two Million Melvins"". J Nurs Care Qual 32:99-103
Berman, Sara E; Clark, Lindsay R; Rivera-Rivera, Leonardo A et al. (2017) Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity. J Alzheimers Dis 60:243-252
Betthauser, Tobey J; Lao, Patrick J; Murali, Dhanabalan et al. (2017) In Vivo Comparison of Tau Radioligands 18F-THK-5351 and 18F-THK-5317. J Nucl Med 58:996-1002
Hoy, Andrew R; Ly, Martina; Carlsson, Cynthia M et al. (2017) Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging. PLoS One 12:e0173982

Showing the most recent 10 out of 288 publications